spacer
home > pmps > winter 2017 > working together
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Working Together

If the pharmaceutical supply chain was a living, breathing creature, it would probably be the microscopic water flea. Daphnia pulex was the first crustacean to have its genome sequenced, and results showed that it has 31,000 genes – 25% more than us humans. Just like the genetic complexity of the water flea was a challenge for scientists, the sophisticated pharma supply chain is now changing the way the industry operates.

The rise of emerging markets and the different geographic standards used around the world are additional challenges that manufacturers need to address. As always in the pharma sector, the complex regulatory landscape has a significant impact on companies. This includes widely recognised guidelines such as those from the FDA and their European counterparts, as well as client standards and environmental legislation. All of these factors are contributing to making the supply chain nearly impossible to navigate.

Current Situation

As new markets and technologies emerge in the pharma field, manufacturers are starting to feel the pressure of working with a higher number of suppliers, partners and distributors. They often produce drugs for pharmacies or specific patients, rather than wholesale – this means that the industry is starting to be driven by demand rather than forecast. The medicines themselves are becoming progressively complex and bespoke, meaning that the production of mini batches or personalised medicine is another rising trend.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Darren Halford is Sales Director at obsolete components supplier EU Automation. Previously, he has worked as a recruitment consultant, recommending new employment opportunities to senior construction professionals. Darren oversees all sales and service operations and has been with the company since its inception in May 2009.
spacer
Darren Halford
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement